Abstract
The aim of this study was to evaluate the short- and long-term outcomes of exclusive enteral nutrition (EEN) versus corticosteroids (CS) as induction therapy, in a cohort of pediatric patients with Crohn’s disease (CD). A retrospective study of patients with CD has been conducted. Clinical characteristics, laboratory parameters, and pediatric Crohn’s disease activity index (PCDAI) were evaluated at diagnosis and at different follow-up points. Subjects were divided in EEN-induction group, receiving EEN, and CS-induction group, treated with oral CS. We evaluated 47 patients in the EEN-induction group and 21 patients in the CS-induction group. After 8 weeks from diagnosis, we detected a significant improvement in CRP (p = 0.001) and albumin (p = 0.05), in EEN-induction group compared with the CS-induction group. PCDAI was significantly lower in the EEN-induction group versus the CS-induction group after 8 weeks (p = 0.04) and 1 year (p = 0.03) of follow-up. After 2 years from diagnosis, the number of subjects needing immunomodulators (IMM, azathioprine or methotrexate) was significantly higher in the CS-induction group compared with the EEN-induction group (p = 0.02).
Conclusion: EEN has the same effectiveness of CS therapy in induction of remission but seems to have a more pronounced effect on disease activity. In our cohort, the need to use IMM seems to be reduced in subjects initially treated with EEN.
What is Known: • Exclusive enteral nutrition (EEN) has the same effectiveness of corticosteroids (CS) in the induction of remission in pediatric Crohn’s disease. • EEN offers numerous advantages over CS, in terms of improved nutrition and mucosal healing. | |
What is New: • Induction of remission with EEN seems to have a more pronounced effect on disease activity compared to induction with CS. • In our cohort, induction of remission with EEN seems to reduce the need of therapy with immunomodulators at 2 years of follow-up. |
Similar content being viewed by others
Abbreviations
- AZT:
-
Azathioprine
- BMI:
-
Body mass index
- CD:
-
Crohn’s disease
- CS:
-
Corticosteroids
- ECCO:
-
European Crohn’s and Colitis Organization
- EEN:
-
Exclusive enteral nutrition
- EIM:
-
Extra-intestinal manifestations
- ESPGHAN:
-
European Society for Pediatric Gastroenterology, Hepatology and Nutrition
- IFX:
-
Infliximab
- PCDAI:
-
Pediatric Crohn’s Disease Activity Index
- IMM:
-
Immunomodulators
- MTX:
-
Methotrexate
References
Shen YM, Wu JF, Chen LH et al (2011) Characteristics and incidences of pediatric Crohn’s disease in decades before and after 2000. Pediatr Neonatol 52:317–320
Gasparetto M, Guariso G, Pozza LV et al (2016) Clinical course and outcomes of diagnosing inflammatory bowel disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy. BMC Gastroenterol 16:35
Shamir R, Phillip M, Levine A (2007) Growth retardation in pediatric Crohn’s disease: pathogenesis and interventions. Inflamm Bowel Dis 13(5):620–628
Walters TD, Griffiths AM (2009) Mechanisms of growth impairment in pediatric Crohn’s disease. Nat Rev Gastroenterol Hepatol 6(9):513–523
Griffiths AM, Nguyen P, Smith C et al (1993) Growth and clinical course of children with Crohn’s disease. Gut 34(7):939–943
Ley D, Duhamel A, Behal H, Vasseur F, Sarter H, Michaud L, Gower-Rousseau C, Turck D (2016) Growth pattern in pediatric Crohn’s disease is related to inflammatory status. J Pediatr Gastroenterol Nutr 63(6):637–643
Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, Amil Dias J, Barabino A, Braegger CP, Bronsky J, Buderus S, Martín-de-Carpi J, de Ridder L, Fagerberg UL, Hugot JP, Kierkus J, Kolacek S, Koletzko S, Lionetti P, Miele E, Navas López VM, Paerregaard A, Russell RK, Serban DE, Shaoul R, van Rheenen P, Veereman G, Weiss B, Wilson D, Dignass A, Eliakim A, Winter H, Turner D, European Crohn's and Colitis Organisation, European Society of Pediatric Gastroenterology, Hepatology and Nutrition (2014) Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohns Colitis 8(10):1179–1207
Perrin JM, Kuhlthau K, Chughtai A et al (2008) Measuring quality of life in pediatric patients with inflammatory bowel disease: psychometric and clinical characteristics. J Pediatr Gastroenterol Nutr 46(2):164–171
Whitten KE, Rogers P, Ooi CK, Day AS (2012) International survey of enteral nutrition protocols used in children with Crohn’s disease. J Dig Dis 13(2):107–112
Heuschkel RB, Menache CC, Megerian JT, Baird AE (2000) Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr 31(1):8–15
de Bie C, Kindermann A, Escher J (2013) Use of exclusive enteral nutrition in paediatric Crohn’s disease in the Netherlands. J Crohns Colitis 7(4):263–270
Grover Z, Burgess C, Muir R, Reilly C, Lewindon PJ (2016) Early mucosal healing with exclusive enteral nutrition is associated with improvement outcomes in newly diagnosed children with luminal Crohn’s disease. J Crohns Colitis 10(10):1159–1164
Dziechciarz P, Horvath A, Shamir R et al (2007) Meta-analysis: enteral nutrition in active Crohn’s disease in children. Aliment Pharmacol Ther 26(6):795–806
Day AS, Lopez RN (2015) Exclusive enteral nutrition in children with Crohn’s disease. World J Gastroenterol 21(22):6809–6816
Narula N, Dhillon A, Zhang D et al (2018) Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev 4:CD000542
Lambert B, Lemberg DA, Leach ST, Day AS (2012) Longer-term outcomes of nutritional management of Crohn’s disease in children. Dig Dis Sci 57(8):2171–2177
Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, Griffiths AM, Katz AJ, Grand RJ, Boyle JT, Michener WM, Levy JS, Lesser ML (1991) Development and validation of a pediatric Crohn’s disease activity index. J Pediatr Gastroenterol Nutr 12(4):439–447
Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, Fell J, Ruemmele FM, Walters T, Sherlock M, Dubinsky M, Hyams JS (2011) Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris Classification. Inflamm Bowel Dis 17:1314–1321
Van Assche G, Dignass A, Reinisch W, van der Woude J et al (2010) The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: special situations. J Crohns Colitis 4(1):63–101
Greenberg GR, Fleming CR, Jeejeebhoy KN et al (1998) Controlled trial of bowel rest and nutritional support in the management of Crohn’s disease. Gut 29(10):1309–1315
Budd GR, Aitchison A, Day AS et al (2017) The effects of polymeric formula on enterocyte differentiation. Innate Immun 23(3):240–248
De Jong NS, Leach ST, Day AS (2007) Polymeric formula has direct anti-inflammatory effects on enterocytes in an in vitro model of intestinal inflammation. Dig Dis Sci 52(9):2029–2036
Lionetti P, Callegari ML, Ferrari S et al (2005) Enteral nutrition and microflora in pediatric Crohn’s disease. J Parenter Enter Nutr 29(4 Suppl):S173–S175 discussion S175-8, S184-8
Bannerjee K, Camacho-Hubner C, Babinska K (2004) Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 38(3):270–275
Swaminath A, Feathers A, Ananthakrishnan AN (2017) Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn’s disease. Alimen Pharmacol Ther 46(7):645–656
Tung J, Loftus EV Jr, Freese DK et al (2006) A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis 12(12):1093–1100
Yu Y, Chen KC, Chen J (2019) Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn’s disease: a meta-analysis. World J Pediatr 15(1):26–36
Borrelli O, Cordischi L, Cirulli M, Paganelli M, Labalestra V, Uccini S, Russo PM, Cucchiara S (2006) Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn’s disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol 4(6):744–753
Cohen-Dolev N, Sladek M, Hussey M et al (2018) Differences in outcomes over time with exclusive enteral nutrition compared with steroids in children with mild to moderate Crohn’s disease: results from the GROWTH CD study. J Crohn's Colitis 12(3):306–312
Fell JM, Paintin M, Arnaud-Battandier F et al (2000) Mucosal healing and a fall in mucosal pro-inflammatory cytokine m-RNA induced by a specific oral polymeric diet in pediatric Crohn’s disease. Aliment Pharmacol Ther 14(3):281–289
Newby EA, Sawczenko A, Thomas AG et al (2005) Interventions for growth failure in childhood Crohn’s disease. Cochrane Database Syst Rev 3:CD003873
Grover Z, Muir R, Lewindon P (2014) Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in pediatric Crohn’s disease. J Gastroenterol 49(4):638–645
Berni Canani R, Terrin G, Borrelli O, Romano MT, Manguso F, Coruzzo A, D’Armiento F, Romeo EF, Cucchiara S (2006) Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn’s disease. Dig Liver Dis 38:381–387
Funding
There is no funding source.
Author information
Authors and Affiliations
Contributions
E.S: Dr. Scarpato conceptualized the study, acquired the data, performed the data analysis, drafted the initial manuscript, and approved the final manuscript as submitted. Dr. Scarpato agrees to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
C.S.: Dr. Strisciuglio conceptualized the study, acquired the data, performed the data analysis, drafted the initial manuscript, and approved the final manuscript as submitted. Dr. Strisciuglio agrees to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
M. M.: Dr. Martinelli conceptualized the study, performed the data analysis, drafted the initial manuscript, and approved the final manuscript as submitted. Dr. Martinelli agrees to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
M. R.: Dr. Russo acquired the data, performed the data analysis, drafted the initial manuscript, and approved the final manuscript as submitted. Dr. Russo agrees to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
S. C.: Dr. Cenni acquired the data, drafted the initial manuscript, and approved the final manuscript as submitted. Dr. Cenni agrees to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
M. C.: Dr. Casertano acquired the data, drafted the initial manuscript, and approved the final manuscript as submitted. Dr. Casertano agrees to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
M. R. S.: Dr. Serra acquired the data, performed the data analysis, drafted the initial manuscript, and approved the final manuscript as submitted. Dr. Serra agrees to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
A. S.: Dr. Staiano contributed to conception of the study, revised the article critically for important intellectual content, and approved the final manuscript as submitted. Dr. Staiano agrees to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
E. M.: Dr. Miele contributed to conception of the study, revised the article critically for important intellectual content, and approved the final manuscript as submitted. Dr. Miele agrees to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors. The Institutional Review Board of the University of Naples “Federico II” approved the study protocol and questionnaire with the registration number 128/18. The study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Additional information
Communicated by Peter de Winter
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Scarpato, E., Strisciuglio, C., Martinelli, M. et al. Exclusive enteral nutrition effect on the clinical course of pediatric Crohn’s disease: a single center experience. Eur J Pediatr 179, 1925–1934 (2020). https://doi.org/10.1007/s00431-020-03753-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-020-03753-x